How Can a Newborn Get Meningitis?

Newborns most commonly get meningitis when bacteria from their mother’s body enter theirs during or shortly before birth, though infections can also arrive through hospital environments, contaminated feeding supplies, or viruses picked up in the first weeks of life. The disease is split into early-onset and late-onset forms, each linked to different pathogens, risk factors, and routes of transmission. Because a newborn’s immune defenses and physical barriers are still developing, organisms that pose little threat to older children can invade the bloodstream and reach the brain’s protective membranes with relative ease.

The Birth Canal as a Starting Point

The single biggest source of early neonatal meningitis is bacteria the baby encounters while passing through the birth canal. Group B Streptococcus (GBS) is the most common bacterial cause of meningitis in infants under 90 days old, and it lives harmlessly in the gastrointestinal or genitourinary tracts of a substantial number of pregnant women.¹ During delivery, the baby swallows or inhales these bacteria. A classic study found that about 58% of infants whose mothers carried GBS during labor picked up the organism, compared with 12% of infants born to non-carriers, and the likelihood of transmission appeared to be related to how heavily colonized the mother was.² Picking up the bacteria does not automatically mean a baby gets sick, but in a small fraction of colonized infants, the organisms enter the bloodstream and then the central nervous system.

GBS is not the only threat in the birth canal. Escherichia coli, especially the K1 strain, is the leading gram-negative cause of neonatal meningitis. This strain has a particular ability to penetrate the blood-brain barrier, the tightly sealed lining of blood vessels in the brain that normally keeps pathogens out.³ Listeria monocytogenes, a bacterium found in certain foods, can also infect a pregnant woman without causing dramatic symptoms, then cross the placenta or colonize the birth canal, leading either to an early-onset sepsis picture or a late-onset meningitis in the baby.⁴

Early-Onset Versus Late-Onset Disease

Clinicians split neonatal meningitis into two windows. Early-onset disease develops within the first 72 hours of life and is strongly tied to organisms acquired from the mother during labor and delivery. GBS, E. coli, and Listeria dominate this window.⁵ Late-onset disease appears between roughly 3 and 28 days of life and has a broader range of sources. The same organisms can still be responsible, but gram-negative bacteria other than E. coli and staphylococcal species become more prominent, because the baby has now been exposed to organisms in the hospital, at home, and through caregivers’ hands.

Perinatal conditions help explain why some babies develop early-onset meningitis while most do not. Prolonged rupture of the membranes before delivery, chorioamnionitis (infection of the amniotic fluid and surrounding membranes), and amniotic fluid contamination were all more common among early-onset cases in a study comparing the two groups.⁶ That same study found that early-onset cases had worse outcomes overall, with higher rates of convulsions and intracranial bleeding. Late-onset cases, by contrast, were more likely to present with fever and elevated inflammatory markers in the blood, making them somewhat easier to spot clinically.

Why Newborns Are Uniquely Vulnerable

Adults encounter many of the same bacteria every day without developing meningitis. The reason newborns are at such disproportionate risk comes down to two things: an immature immune system and physical barriers that have not yet tightened up. Research using animal models has shown that the neonatal gut lining and the choroid plexus, a structure in the brain involved in producing cerebrospinal fluid, both have looser cell-to-cell junctions in early life. This looseness makes it easier for bacteria to cross from the intestine into the bloodstream and then from the blood into the brain.⁷ The newborn gut microbiome, which in older people helps crowd out dangerous bacteria, is still sparse and undeveloped, giving pathogens like GBS room to colonize and then cross the intestinal wall.

Chorioamnionitis during pregnancy may compound this vulnerability. Inflammation in the womb can reshape how the baby’s immune system develops during critical windows, leaving the newborn both prone to chronic inflammatory responses and paradoxically less able to fight off infection after birth.⁸ This dual effect helps explain why chorioamnionitis is consistently flagged as a risk factor for neonatal meningitis across studies.

Viral Routes of Infection

Not all neonatal meningitis is bacterial. Viruses cause a meaningful share of cases, and the two most important culprits in newborns are herpes simplex virus (HSV) and enteroviruses. HSV transmission happens predominantly during delivery, when the baby passes through an infected birth canal. The virus can produce several distinct patterns of disease in a newborn, including a form that specifically targets the central nervous system.⁹ HSV meningitis in newborns is a medical emergency, and the prognosis varies sharply depending on how quickly treatment starts and which pattern of disease appears.

Enteroviruses are actually the most common viral cause of meningitis in very young infants. A surveillance study across the UK and Ireland identified over 700 cases in infants under 90 days during a 13-month period, with enterovirus accounting for the vast majority. The most common symptoms were fever, irritability, and reduced feeding. While the mortality rate was low, about one in nine enterovirus cases and nearly one in four parechovirus cases required intensive care.¹⁰ Enteroviruses spread through respiratory droplets and fecal-oral contact, meaning a baby can catch them from family members, caregivers, or other close contacts after birth. The reassuring finding is that survivors of enteroviral meningitis generally did well at follow-up, with no sensorineural hearing loss detected in the cohort that underwent formal testing.

Hospital-Acquired Infections and the NICU

For premature or critically ill newborns spending time in a neonatal intensive care unit, the hospital itself becomes a source of infection. Invasive medical equipment, including breathing tubes, central venous catheters, and peripherally inserted central lines, creates direct routes for bacteria to enter the bloodstream. A ten-year review of hospital-acquired meningitis in one NICU found that the types of bacteria causing meningitis shifted over time as the unit treated smaller, sicker babies who required more invasive interventions and broader antibiotic use.¹¹ Acinetobacter species, which thrive in hospital environments and often resist multiple antibiotics, emerged as a significant pathogen in that setting. Prematurity and low birth weight were key risk factors, not because these babies are inherently more “fragile” in a vague sense, but because they require the very devices and prolonged stays that create exposure opportunities.

Extremely low birth weight infants also face risk from fungal meningitis, particularly from Candida species. These infections are rare in full-term babies but carry a substantially increased risk of death or neurodevelopmental impairment in the smallest premature infants.¹²

Contaminated Formula and Feeding Equipment

A less well-known but serious route of infection involves what a newborn is fed and the equipment used to prepare it. Cronobacter sakazakii is a gram-negative bacterium found widely in the environment that causes severe and often fatal meningitis in young infants. Powdered infant formula has been identified as a primary vehicle for transmission, and contaminated breast pump equipment has also been implicated.¹³ Powdered formula is not sterile, and if it is prepared with water that is not hot enough or stored at room temperature too long, Cronobacter can multiply rapidly.

The link between contaminated formula and neonatal meningitis has been documented for decades. In one outbreak investigation in Iceland, the Cronobacter strains isolated from three infected neonates were indistinguishable from strains grown from the powdered formula used in the hospital, while no environmental sources in the NICU itself tested positive.¹⁴ This sort of forensic matching underscores why safe preparation and storage of formula is genuinely important, not just a box-checking exercise on a hospital leaflet. The practical steps matter: using water at the correct temperature when reconstituting powdered formula, not leaving prepared bottles at room temperature, and thoroughly cleaning and sanitizing breast pump parts after every use.¹⁵

Unusual Anatomical Vulnerabilities

In rare cases, a newborn develops meningitis not from exposure to a particular pathogen but because of a hidden structural defect that provides bacteria a direct route to the central nervous system. A congenital dermal sinus tract, a type of closed neural tube defect, connects the skin surface to a deeper layer near the spinal cord. If bacteria from the skin travel along this tract, they can reach the cerebrospinal fluid and cause meningitis. These tracts are uncommon and easily missed on physical exam, but they become suspected when a baby has recurrent episodes of bacterial meningitis without an obvious source.¹⁶ Dedicated imaging, usually MRI, is needed to identify the tract, and surgical correction can prevent further infections.

Why Diagnosis Is Difficult in Newborns

One of the frustrating realities of neonatal meningitis is that the symptoms are maddeningly nonspecific. A newborn with meningitis may simply be irritable, feed poorly, or have an unstable temperature. The classic signs that alert clinicians to meningitis in older children, such as a stiff neck or a bulging fontanelle, are unreliable in the youngest patients. A study of infants under 60 days in Kenya found that the standard signs recommended by the World Health Organization had a sensitivity of only 58% for confirmed meningitis, meaning they missed more than four in ten cases. Adding a history of fever improved sensitivity to 89% but drove specificity down to 26%, meaning many uninfected babies would also be flagged.¹⁷

This is why clinicians have a low threshold for performing a lumbar puncture, the definitive diagnostic step, in any newborn with signs of possible infection. Even the spinal fluid results can be tricky to read: one study found that using any white blood cells at all in the cerebrospinal fluid as a cutoff caught 97% of culture-proven cases, but with a specificity of only 11%, flagging nearly every sample. Raising the threshold to a higher white cell count improved specificity to 81% but missed about one in five true infections.¹⁸ Glucose and protein levels in the fluid were not reliably accurate for diagnosis either. The upshot is that clinicians often start antibiotics before the culture results come back, simply because waiting carries too much risk.

Screening and Prevention Before Birth

The most established prevention strategy targets GBS. In many high-income countries, pregnant women are screened late in pregnancy for GBS colonization, and those who test positive receive intravenous antibiotics during labor. A meta-analysis of 17 studies found that this screening-based approach was associated with a roughly 57% lower risk of early-onset GBS disease compared with a strategy that relied on clinical risk factors alone, and about a 69% lower risk compared with having no prevention policy at all.¹⁹ A Canadian population study similarly found that maternal screening was associated with a 40% reduction in overall infant GBS disease.²⁰

Despite these gains, there is an important caveat. A Cochrane review of the randomized trials specifically testing intrapartum antibiotics in colonized women found that while the treatment appeared to reduce early-onset GBS infection, the trials themselves had a high risk of bias, and the authors could not confidently recommend the practice based on the trial evidence alone.²¹ In practice, the observational data is strong enough that screening remains standard of care in the US, UK, and Canada. The limitation is that intrapartum antibiotics do very little for late-onset disease, since that form involves bacteria picked up after delivery. GBS meningitis rates overall have not declined since the 1970s despite decades of prophylaxis, because the late-onset cases persist.¹

The Protective Role of Breastfeeding

Breast milk delivers immune factors that the newborn cannot yet produce on its own. The most important of these is secretory IgA, an antibody produced by immune cells that have migrated from the mother’s gut to the mammary glands. Because these antibodies are shaped by the mother’s own recent microbial exposures, they are specifically targeted against the kinds of bacteria the baby is most likely to encounter. Breastfeeding helps modulate the early colonization of the infant’s gut and limits bacterial translocation across the gut lining, which is one of the key steps in how neonatal sepsis and meningitis develop.²² This does not make breastfeeding a guarantee against meningitis, but it does offer a measurable layer of protection during the window when the baby’s own defenses are weakest.

Long-Term Outcomes After Neonatal Meningitis

Surviving neonatal meningitis is not always the end of the story. A systematic review and meta-analysis examining the impact of meningitis on intelligence and development found that bacterial meningitis survivors had roughly a 5-point reduction in IQ compared with healthy peers, and were about five times more likely to fall below an IQ of 70. Developmental delays were reported across cognitive, social, language, and motor domains, with an average deficit of about half a standard deviation in younger survivors.²³ Viral meningitis, by contrast, did not show a measurable impact on IQ. The distinction matters for parents processing a diagnosis: the pathogen driving the infection shapes not just the acute illness but the developmental follow-up that may be needed in the years ahead.

How Geography Shapes the Picture

Where a baby is born dramatically changes both the risk and the likely outcome of neonatal meningitis. A systematic review of neonatal meningitis in lower-income countries estimated mortality at 40 to 58%, compared with roughly 10% in wealthier settings.²⁴ The gap is not just about treatment access, though that matters enormously. The spectrum of bacteria involved also differs: while GBS, E. coli, and Listeria dominate in high-income countries, lower-income settings see a broader and more variable mix of gram-negative and gram-positive organisms. GBS prevention through maternal screening and intrapartum antibiotics, the strategy that has reduced early-onset disease in wealthy nations, is often not available in settings where the infrastructure for universal late-pregnancy screening does not exist. Prolonged rupture of membranes and maternal urinary tract infections, both associated with higher rates of GBS colonization, remain common and underdiagnosed risk factors in resource-limited settings.²⁵ For families in these regions, the practical calculus is different: clean delivery conditions, prompt treatment of maternal infections, and breastfeeding take on even greater weight as frontline defenses against a disease that remains far deadlier than it needs to be.